---
title: "First patients enrolled in high-risk PCI study of Supira pVAD"
date: "2024-11-21T16:09:54.000Z"
publishedDate: "21 novembre 2024"
summary: "Supira Medical has announced the initiation and successful patient enrolment in the company&#8217;s US early feasibility study (EFS). The multicentre, prospective, single arm clinical study will evaluate the safety and feasibility of Supira&#8217;s low-profile, high-flow percutaneous ventricular assist device (pVAD) in patients undergoing high-risk percutaneous coronary intervention (PCI)."
importance: ""
sourceUrl: "https://cardiovascularnews.com/first-patients-enrolled-in-high-risk-pci-study-of-supira-pvad/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-11-21-first-patients-enrolled-in-high-risk-pci-study-of-supira-pvad"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/01/Medical-students-1024x768-1.jpeg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/first-patients-enrolled-in-high-risk-pci-study-of-supira-pvad/"
---

![First patients enrolled in high-risk PCI study of Supira pVAD](https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/01/Medical-students-1024x768-1.jpeg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/first-patients-enrolled-in-high-risk-pci-study-of-supira-pvad/*

## L’essentiel

Supira Medical has announced the initiation and successful patient enrolment in the company&#8217;s US early feasibility study (EFS). The multicentre, prospective, single arm clinical study will evaluate the safety and feasibility of Supira&#8217;s low-profile, high-flow percutaneous ventricular assist device (pVAD) in patients undergoing high-risk percutaneous coronary intervention (PCI).

## Lien source

https://cardiovascularnews.com/first-patients-enrolled-in-high-risk-pci-study-of-supira-pvad/
